Anta Sports Expands Global Footprint With Strategic Puma Stake 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
BURLINGTON, Mass., Feb. 28, 2018 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in seven investor conferences in March.
Steven Chehames, Investor Relations, will participate in the 2018 BTIG Healthcare Conference on Thursday, March 1, 2018 in Snowbird, UT.
George LeMaitre, Chairman & CEO, is scheduled to present at the 30th Annual ROTH Conference on Tuesday, March 13, 2018 at the Ritz-Carlton Hotel in Laguna Niguel, CA. The Company’s presentation is scheduled to begin at 10:00 AM PDT.
David Roberts, President, is scheduled to present at the Barclays Global Healthcare Conference on Wednesday, March 14, 2018 at the Loews Miami Beach Hotel in Miami Beach, FL. The Company’s presentation is scheduled to begin at 11:15 AM EDT.
JJ Pellegrino, Chief Financial Officer, will participate in the Morgan Stanley Healthcare Corporate Access Day on Tuesday, March 20, 2018 at the Boston Harbor Hotel in Boston, MA.
David Roberts, President, is scheduled to present at the Oppenheimer Annual Healthcare Conference on Wednesday, March 21, 2018 at the Westin New York Grand Central Hotel in New York City. The Company’s presentation is scheduled to begin at 3:55 PM EDT.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Needham Healthcare Conference on Wednesday, March 28, 2018 at the Westin New York Grand Central Hotel in New York City. The Company’s presentation is scheduled to begin at 3:30 PM EDT.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Sidoti Spring Conference on Thursday, March 29, 2018 at the NYC Marriott Marquis Hotel in New York City. The Company’s presentation is scheduled to begin at 3:50 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc.
Investor Relations
Steven Chehames
+1-781-425-1659
[email protected]
